. Author manuscript; available in PMC: 2021 Sep 1.

Published in final edited form as: Circ Arrhythm Electrophysiol. 2020 Jul 23;13(9):e007944. doi: 10.1161/CIRCEP.119.007944

Table 4: Baseline characteristics by complication occurrence:

Demographics and medical history for all included patients and by complication occurrence. Data presented as median (IQR) or N (%) as appropriate

	Overall	No complication	Complication	P-value
N	3138^*	2978 (94.9%)	160 (5.1%)
Age, years	65 (58-71)	65 (58-71)	68 (62-73)	<0.0001
Female	1131 (36.0%)	1053 (35.4%)	78 (48.8%)	0.0006
Hypertension	2121 (67.6%)	1999 (67.1%)	122 (76.2%)	0.0163
OSA	999 (31.8%)	949 (31.9%)	50 (31.3%)	0.8704
Coronary artery disease	593 (18.9%)	555 (18.6%)	38 (23.8%)	0.1076
Diabetes Mellitus	589 (18.8%)	563 (18.9%)	26 (16.2%)	0.4021
Heart Failure	570 (18.2%)	525 (17.6%)	45 (28.1%)	0.0008
LVEF <40%	243 (8.2%)	229 (8.1%)	14 (9.2%)	0.6488
Thyroid disease	505 (16.1%)	473 (15.8%)	32 (20.0%)	0.1675
On dialysis	6 (0.2%)	6 (0.2%)	0 (0.0%)	0.5699
Stage 3 CKD	622 (24.3%)	576 (23.9%)	46 (31.3%)	0.0414
Cancer	364 (11.6%)	343 (11.5%)	21 (13.1%)	0.5363
COPD	256 (8.2%)	233 (7.8%)	23 (14.4%)	0.0032
CVA/TIA	245 (7.8%)	231 (7.8%)	14 (8.8%)	0.6483
Peripheral vascular disease	95 (3.0%)	89 (3.0%)	6 (3.8%)	0.5840
Family history of AF	82 (2.6%)	77 (2.6%)	5 (3.1%)	0.6770
Left atrial diameter, cm	4.2 (3.7-4.8)	4.2 (3.7-4.8)	4.4 (3.9-5.0)	0.0490
CHA₂DS₂VASc score	2 (1-4)	2 (1-4)	3 (2-4)	<0.0001
ORBIT bleeding score	1 (0-2)	1 (0-2)	1 (0-3)	<0.0001
HAS-BLED Score	2 (1-2)	1 (1-2)	2 (1.5-3)	<0.0001
Prior major bleeding	94 (3.0%)	86 (2.9%)	8 (5.0%)	0.1241

One patient had missing information regarding complications so these analysis are out of 3,138 patients. Abbreviations: OSA = obstructive sleep apnea; LVEF = left ventricular ejection fraction; CKD = chronic kidney disease; COPD = chronic obstructive pulmonary disease; CVA/TIA = cerebrovascular accident/transient ischemic attack; AF = atrial fibrillation